Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis. - Yan RR; Zhu T; Wang Q; Yang K; Li J; Guan SH (Clinical laboratory, 2021)